Search - tctmd.com

Displaying 121 - 140 of 904

Sort: Relevancy | Date

Presentation TCT 2020

Coronary Stenting in High Bleeding Risk Patients: Is There a Preferred DES for Short DAPT?

Presenter: Davide Capodanno

October 15, 2020

Presentation TCT 2020

Stent Thrombosis: Is There a Standard Approach to Workup and Management?

Presenter: Robert Byrne

October 15, 2020

Presentation TCT 2020

In-Stent-Restenosis: Angioplasty With Drug-Coated Balloon or Repeat Stenting With DES – Which Treatment for Which Patient?

Presenter: Fernando Alfonso

October 15, 2020

Presentation TCT 2020

TCT ID 3: Treatment With Icosapent Ethyl to Reduce Ischemic Events in Patients With Prior Percutaneous Coronary Intervention – Insights From REDUCE-IT PCI

Presenter: Benjamin Peterson

October 15, 2020

News Conference News TCT 2020

IVUS-Guided PCI Gains Support With Longer-Term ULTIMATE Results

Todd Neale

October 15, 2020

News Conference News TCT 2020

Shorter DAPT Succeeds in Xience-Treated Patients at High Bleeding Risk

Caitlin E. Cox

October 15, 2020

Presentation TCT 2020

1-Year Outcomes of Patients with Residual Physiologic Ischemia After Percutaneous Coronary Intervention: The DEFINE PCI Trial

Presenter: Manesh Patel

October 15, 2020

Presentation TCT 2020

Featured Clinical Research: (TCT36010) MOTIV BTK Pilot Study – Initial Safety and Performance Study of the MOTIV Sirolimus-Eluting Bioresorbable Coronary Scaffold; Initial Report on First 10 Patients

Presenter: Michel Bosiers

October 15, 2020

News Conference News TCT 2020

DISRUPT CAD III: Lithotripsy Boosts Stent Expansion in Highly Calcified Lesions

L.A. McKeown

October 15, 2020

Presentation TCT 2020

Intravascular Lithotripsy for Treatment of Severely Calcified Coronary Artery Disease: The Disrupt CAD III Study

Presenter: Dean J. Kereiakes

October 15, 2020

Presentation TCT 2020

In My Opinion: How Should Revascularization Guidelines Change After ISCHEMIA?

Presenter: Davide Capodanno

October 15, 2020

News Conference News TCT 2020

Acurate Neo Fails to Match Results of CoreValve Evolut: SCOPE 2

Michael O'Riordan

October 15, 2020

News Conference News TCT 2020

Efficacy Eludes TriGUARD 3 Cerebral Protection Device: REFLECT II

Todd Neale

October 15, 2020

Presentation TCT 2020

ISCHEMIA in Perspective: Updated Meta-Analysis on PCI in SIHD

Presenter: Sripal Bangalore

October 15, 2020

Presentation TCT 2020

Critical Analysis and Clinical Implications From ISCHEMIA

Presenter: David Maron

October 15, 2020

Presentation TCT 2020

Yes! With the Right Training, Everyone Can (and Should) Do CTO PCI!

Presenter: Simon Walsh

October 15, 2020

Presentation TCT 2020

A Universal Nomenclature for CTO Terminology and Standardization of CTO PCI Trials: Introduction to CTO-ARC

Presenter: Luiz Ybarra

October 15, 2020

Presentation TCT 2020

Debate 2: Should CTO PCI Be Performed at Most Centers and by Most Operators? - No! CTO PCI Should Only Be Done by the Experts!

Presenter: Gerald Werner

October 15, 2020

Presentation TCT 2020

Device-Based Approaches to Infarct Size Reduction

Presenter: Giovanni Luigi De Maria

October 15, 2020

News Conference News TCT 2020

Bivalirudin vs Heparin Patient-Level Meta-analysis Stirs an Old Debate

Shelley Wood

October 14, 2020

Advertisement

Coronary Stenting in High Bleeding Risk Patients: Is There a Preferred DES for Short DAPT?

Stent Thrombosis: Is There a Standard Approach to Workup and Management?

In-Stent-Restenosis: Angioplasty With Drug-Coated Balloon or Repeat Stenting With DES – Which Treatment for Which Patient?

TCT ID 3: Treatment With Icosapent Ethyl to Reduce Ischemic Events in Patients With Prior Percutaneous Coronary Intervention – Insights From REDUCE-IT PCI

IVUS-Guided PCI Gains Support With Longer-Term ULTIMATE Results

Shorter DAPT Succeeds in Xience-Treated Patients at High Bleeding Risk

1-Year Outcomes of Patients with Residual Physiologic Ischemia After Percutaneous Coronary Intervention: The DEFINE PCI Trial

Featured Clinical Research: (TCT36010) MOTIV BTK Pilot Study – Initial Safety and Performance Study of the MOTIV Sirolimus-Eluting Bioresorbable Coronary Scaffold; Initial Report on First 10 Patients

DISRUPT CAD III: Lithotripsy Boosts Stent Expansion in Highly Calcified Lesions

Intravascular Lithotripsy for Treatment of Severely Calcified Coronary Artery Disease: The Disrupt CAD III Study

In My Opinion: How Should Revascularization Guidelines Change After ISCHEMIA?

Acurate Neo Fails to Match Results of CoreValve Evolut: SCOPE 2

Efficacy Eludes TriGUARD 3 Cerebral Protection Device: REFLECT II

ISCHEMIA in Perspective: Updated Meta-Analysis on PCI in SIHD

Critical Analysis and Clinical Implications From ISCHEMIA

Yes! With the Right Training, Everyone Can (and Should) Do CTO PCI!

A Universal Nomenclature for CTO Terminology and Standardization of CTO PCI Trials: Introduction to CTO-ARC

Debate 2: Should CTO PCI Be Performed at Most Centers and by Most Operators? - No! CTO PCI Should Only Be Done by the Experts!

Device-Based Approaches to Infarct Size Reduction

Bivalirudin vs Heparin Patient-Level Meta-analysis Stirs an Old Debate

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content